These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7214544)

  • 1. Opposite modulation of lymph node cell and spleen cell responses to mitogens by muramyl dipeptide and its desmethyl analog.
    Brummer E; Stevens DA
    Cell Immunol; 1981 Mar; 59(1):195-204. PubMed ID: 7214544
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms in opposite modulation of spleen cell and lymph node cell responses to mitogens following muramyl dipeptide treatment in vivo.
    Brummer E; Stevens DA
    Cell Immunol; 1985 Apr; 91(2):505-14. PubMed ID: 3995590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of mouse natural killer cell activity by muramyl dipeptide and its analogs.
    Sharma SD; Tsai V; Krahenbuhl JL; Remington JS
    Cell Immunol; 1981 Jul; 62(1):101-9. PubMed ID: 7261067
    [No Abstract]   [Full Text] [Related]  

  • 4. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
    Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
    Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of in vitro immune responses of murine Peyer's patch cultures by concanavalin A, muramyl dipeptide and lipopolysaccharide.
    Kiyono H; McGhee JR; Kearney JF; Michalek SM
    Scand J Immunol; 1982 Apr; 15(4):329-39. PubMed ID: 7048508
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of the mitogenicity of muramyl dipeptide.
    Wood DD; Staruch MJ
    Int J Immunopharmacol; 1981; 3(1):31-44. PubMed ID: 6975247
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
    Löwy I; Leclerc C; Bourgeois E; Chedid L
    J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increasing the sensitivity of murine splenic cells to interleukin-2 after in vivo exposure to lipopolysaccharide, muramyl dipeptide and concanavalin A].
    Rakhmilevich AL; Obernikhin SS; Rakhimova MS
    Antibiot Khimioter; 1989 Nov; 34(11):839-41. PubMed ID: 2633700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of T- and B-lymphocyte mitogens on interactions between lymphocytes and macrophages.
    Stoecker CA; Rickard BM; Abel CA
    Cell Immunol; 1978 Feb; 35(2):362-77. PubMed ID: 304382
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
    Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
    Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C; Juy D; Bourgeois E; Chedid L
    Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement by muramyl dipeptide of in vitro nude mice responses to a T-dependent antigen.
    Leclerc C; Bourgeois E; Chedid L
    Immunol Commun; 1979; 8(1):55-64. PubMed ID: 311334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes with age in the homing properties and mitogen responses of lymphocytes from normal and leukemia-prone mice.
    Gillette RW; Fox A
    Cell Immunol; 1980 Apr; 51(1):32-41. PubMed ID: 6965888
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs.
    Uemiya M; Saiki I; Kusama T; Azuma I; Yamamura Y
    Microbiol Immunol; 1979; 23(8):821-3. PubMed ID: 120487
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of MDP-Lys(L18), a derivative of MDP, on enhancing host resistance against Hantaan virus infection in newborn mice.
    Yoo YC; Yoshimatsu K; Hatsuse R; Tamura M; Yoshida R; Tono-oka S; Arikawa J; Azuma I
    Vaccine; 1995 Oct; 13(14):1300-5. PubMed ID: 8585284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-related immunocompetence of BALB/c mice. I. Study of immunologic responsiveness of neonatal, weanling, and young adult mice.
    Krzych U; Thurman GB; Goldstein AL; Bressler JP; Strausser HR
    J Immunol; 1979 Dec; 123(6):2568-74. PubMed ID: 159320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
    Carelli C; Audibert F; Chedid L
    Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Adam A; Souvannavong V; Lederer E
    Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.